← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable — 2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 2.0% below its 1-year high (as of 2026-09-17). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 8.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
HAFN
Hafnia Ltd
Valuation N/A
Industrials Risk 41 · Elevated
Price$9.38
Model IV—
P/IV—
Limited data — see page
HAVA
Harvard Ave Acquisition Corp
Valuation N/A
Financial Services
Price$10.21
Model IV—
P/IV—
Limited data — see page
HAVAR
Harvard Ave Acquisition Corp
Valuation N/A
Financial Services
Price$0.15
Model IV—
P/IV—
Limited data — see page
HAWK
HawkEye 360, Inc.
Valuation N/A
Technology Risk 40 · Elevated
Price$16.30
Model IV—
P/IV—
Limited data — see page
HBIO
HARVARD BIOSCIENCE INC
Valuation N/A
Healthcare Risk 52 · Elevated
Price$8.03
Model IV—
P/IV—
Market implies +37.0%/yr vs model +2.0% · above model
HBM
Hudbay Minerals Inc.
Valuation N/A
Basic Materials Risk 27 · Moderate
Price$26.52
Model IV—
P/IV—
Limited data — see page
HBNB
Hotel101 Global Holdings Corp.
Valuation N/A
Consumer Cyclical Risk 32 · Moderate
Price$4.99
Model IV—
P/IV—
Limited data — see page
HCAC
Hall Chadwick Acquisition Corp
Valuation N/A
Financial Services
Price$10.10
Model IV—
P/IV—
Limited data — see page
HCACR
Hall Chadwick Acquisition Corp
Valuation N/A
Financial Services
Price$0.25
Model IV—
P/IV—
Limited data — see page
HCHL
Happy City Holdings Ltd
Valuation N/A
Consumer Cyclical
Price$3.96
Model IV—
P/IV—
Limited data — see page
HCIC
Hennessy Capital Investment Corp. VIII
Valuation N/A
Financial Services
Price$9.99
Model IV—
P/IV—
Limited data — see page
HCICR
Hennessy Capital Investment Corp. VIII
Valuation N/A
Financial Services
Price$0.14
Model IV—
P/IV—
Limited data — see page
HCM
HUTCHMED (China) Ltd
Valuation N/A
Healthcare Risk 50 · Elevated
Price$12.82
Model IV—
P/IV—
Market implies +23.2%/yr vs model +11.4% · above model
HCMA
HCM III ACQUISITION CORP.
Valuation N/A
Financial Services
Price$10.32
Model IV—
P/IV—
Limited data — see page
HCWB
HCW Biologics Inc.
Valuation N/A
Healthcare Risk 41 · Elevated
Price$2.24
Model IV—
P/IV—
Market implies +29.2%/yr vs model +15.0% · above model
HCXY
Hercules Capital, Inc.
Valuation N/A
Unknown Risk 57 · Elevated
Price$25.04
Model IV—
P/IV—
Limited data — see page
HDL
SUPER HI INTERNATIONAL HOLDING LTD.
Valuation N/A
Consumer Cyclical Risk 32 · Moderate
Price$12.05
Model IV—
P/IV—
Limited data — see page
HELP
CYBIN INC.
Valuation N/A
Healthcare Risk 36 · Moderate
Price$13.12
Model IV—
P/IV—
Limited data — see page
HEPS
D-MARKET Electronic Services & Trading
Valuation N/A
Consumer Cyclical Risk 37 · Moderate
Price$2.62
Model IV—
P/IV—
Limited data — see page
HEQ
John Hancock Diversified Income Fund
Valuation N/A
Unknown
Price$11.31
Model IV—
P/IV—
Limited data — see page
HERZ
Herzfeld Credit Income Fund, Inc
Valuation N/A
Unknown
Price$16.13
Model IV—
P/IV—
Limited data — see page
HFRO
HIGHLAND OPPORTUNITIES & INCOME FUND
Valuation N/A
Unknown
Price$7.39
Model IV—
P/IV—
Limited data — see page
HGLB
HIGHLAND GLOBAL ALLOCATION FUND
Valuation N/A
Unknown
Price$7.31
Model IV—
P/IV—
Limited data — see page
HIMX
Himax Technologies, Inc.
Valuation N/A
Technology Risk 44 · Elevated
Price$14.73
Model IV—
P/IV—
Limited data — see page
HIND
Vyome Holdings, Inc
Valuation N/A
Healthcare Risk 36 · Moderate
Price$2.06
Model IV—
P/IV—
Market implies +63.7%/yr vs model +2.0% · above model
HIO
WESTERN ASSET HIGH INCOME OPPORTUNITY FUND INC.
Valuation N/A
Unknown
Price$3.44
Model IV—
P/IV—
Limited data — see page
HITI
High Tide Inc.
Valuation N/A
Consumer Cyclical Risk 36 · Moderate
Price$2.53
Model IV—
P/IV—
Limited data — see page
HKPD
Cellyan Biotechnology Co., Ltd
Valuation N/A
Consumer Defensive Risk 33 · Moderate
Price$0.13
Model IV—
P/IV—
Limited data — see page
HL
HECLA MINING CO/DE/
Valuation N/A
Basic Materials Risk 36 · Moderate
Price$19.78
Model IV—
P/IV—
Market implies +44.0%/yr vs model +8.0% · above model
HLMN
Hillman Solutions Corp.
Valuation N/A
Industrials Risk 60 · High
Price$6.98
Model IV—
P/IV—
Market implies +26.4%/yr vs model +3.3% · above model
HLN
Haleon plc
Valuation N/A
Consumer Defensive Risk 52 · Elevated
Price$9.19
Model IV—
P/IV—
Limited data — see page
HLNE
Hamilton Lane INC
Valuation N/A
Financial Services Risk 43 · Elevated
Price$95.98
Model IV—
P/IV—
Limited data — see page
HLP
Hongli Group Inc.
Valuation N/A
Industrials Risk 28 · Moderate
Price$1.21
Model IV—
P/IV—
Market implies +30.1%/yr vs model +3.0% · above model
HLXC
Helix Acquisition Corp. III
Valuation N/A
Financial Services
Price$10.80
Model IV—
P/IV—
Limited data — see page
HMC
HONDA MOTOR CO LTD
Valuation N/A
Consumer Cyclical Risk 62 · High
Price$32.52
Model IV—
P/IV—
Limited data — see page
HMH
HMH Holding Inc
Valuation N/A
Industrials Risk 55 · Elevated
Price$20.04
Model IV—
P/IV—
Limited data — see page
HMY
HARMONY GOLD MINING CO LTD
Valuation N/A
Basic Materials Risk 31 · Moderate
Price$20.64
Model IV—
P/IV—
Limited data — see page
HOTH
Rocket One Inc.
Valuation N/A
Healthcare Risk 35 · Moderate
Price$0.68
Model IV—
P/IV—
Limited data — see page
HOVR
New Horizon Aircraft Ltd.
Valuation N/A
Industrials Risk 42 · Elevated
Price$1.65
Model IV—
P/IV—
Limited data — see page
HOWL
Werewolf Therapeutics, Inc.
Valuation N/A
Healthcare Risk 49 · Elevated
Price$0.96
Model IV—
P/IV—
Limited data — see page
HPF
JOHN HANCOCK PREFERRED INCOME FUND II
Valuation N/A
Unknown
Price$14.79
Model IV—
P/IV—
Limited data — see page
HPI
JOHN HANCOCK PREFERRED INCOME FUND
Valuation N/A
Unknown
Price$14.90
Model IV—
P/IV—
Limited data — see page
HPS
JOHN HANCOCK PREFERRED INCOME FUND III
Valuation N/A
Unknown
Price$12.86
Model IV—
P/IV—
Limited data — see page
HQ
Horizon Quantum Holdings Ltd.
Valuation N/A
Technology Risk 55 · Elevated
Price$10.34
Model IV—
P/IV—
Limited data — see page
HQH
abrdn Healthcare Investors
Valuation N/A
Unknown
Price$21.76
Model IV—
P/IV—
Limited data — see page
HQL
abrdn Life Sciences Investors
Valuation N/A
Unknown
Price$19.76
Model IV—
P/IV—
Limited data — see page
HSAI
Hesai Group
Valuation N/A
Industrials Risk 42 · Elevated
Price$17.31
Model IV—
P/IV—
Market implies +47.5%/yr vs model +15.0% · above model
HSCS
HeartSciences Inc.
Valuation N/A
Healthcare Risk 33 · Moderate
Price$3.39
Model IV—
P/IV—
Market implies +93.9%/yr vs model +2.0% · above model
HSDT
Solana Co
Valuation N/A
Financial Services Risk 32 · Moderate
Price$2.22
Model IV—
P/IV—
Market implies +78.1%/yr vs model +2.7% · above model
HSLV
Highlander Silver Corp.
Valuation N/A
Basic Materials Risk 45 · Elevated
Price$5.50
Model IV—
P/IV—
Limited data — see page
HSPT
Horizon Space Acquisition II Corp.
Valuation N/A
Financial Services Risk 32 · Moderate
Price$5.80
Model IV—
P/IV—
Limited data — see page
HSPTR
Horizon Space Acquisition II Corp.
Valuation N/A
Financial Services Risk 34 · Moderate
Price$0.46
Model IV—
P/IV—
Limited data — see page
HTCR
HeartCore Enterprises, Inc.
Valuation N/A
Technology Risk 27 · Moderate
Price$1.99
Model IV—
P/IV—
Market implies +44.7%/yr vs model +2.0% · above model
HTD
JOHN HANCOCK TAX-ADVANTAGED DIVIDEND INCOME FUND
Valuation N/A
Unknown
Price$24.74
Model IV—
P/IV—
Limited data — see page
HTGC
Hercules Capital, Inc.
Valuation N/A
Unknown Risk 61 · High
Price$17.41
Model IV—
P/IV—
Limited data — see page
HTLD
HEARTLAND EXPRESS INC
Valuation N/A
Industrials Risk 42 · Elevated
Price$12.34
Model IV—
P/IV—
Market implies +22.7%/yr vs model +50.0% · below model
HTOO
Fusion Fuel Green PLC
Valuation N/A
Industrials Risk 42 · Elevated
Price$2.13
Model IV—
P/IV—
Limited data — see page
HTT
High Templar Tech Ltd
Valuation N/A
Financial Services Risk 35 · Moderate
Price$2.50
Model IV—
P/IV—
Limited data — see page
HUBC
Hub Cyber Security Ltd.
Valuation N/A
Technology Risk 42 · Elevated
Price$0.34
Model IV—
P/IV—
Limited data — see page
HUBCZ
Hub Cyber Security Ltd.
Valuation N/A
Technology Risk 42 · Elevated
Price$0.01
Model IV—
P/IV—
Limited data — see page